In this phase 3 trial, researchers aimed to study the efficacy of tumor bed boost and moderately hypofractionated whole breast irradiation in patients with non-low-risk DCIS.
The firm has developed a whole-blood mRNA test intended for use as a screening tool in women at elevated risk of breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback